Essa Pharma Stock Technical Analysis

EPIX Stock  USD 1.79  0.02  1.10%   
As of the 30th of November, ESSA Pharma shows the Standard Deviation of 10.27, market risk adjusted performance of (0.30), and Mean Deviation of 4.65. ESSA Pharma technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.

ESSA Pharma Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as ESSA, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to ESSA
  
ESSA Pharma's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.

ESSA Pharma Analyst Consensus

Target PriceAdvice# of Analysts
19.4Hold4Odds
ESSA Pharma current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most ESSA analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand ESSA stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of ESSA Pharma, talking to its executives and customers, or listening to ESSA conference calls.
ESSA Analyst Advice Details
ESSA Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of ESSA Pharma technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of ESSA Pharma trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

ESSA Pharma Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was ten with a total number of output elements of fifty-one. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of ESSA Pharma volatility. High ATR values indicate high volatility, and low values indicate low volatility.

ESSA Pharma Trend Analysis

Use this graph to draw trend lines for ESSA Pharma. You can use it to identify possible trend reversals for ESSA Pharma as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual ESSA Pharma price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

ESSA Pharma Best Fit Change Line

The following chart estimates an ordinary least squares regression model for ESSA Pharma applied against its price change over selected period. The best fit line has a slop of   0.1  , which may suggest that ESSA Pharma market price will keep on failing further. It has 122 observation points and a regression sum of squares at 383.7, which is the sum of squared deviations for the predicted ESSA Pharma price change compared to its average price change.

About ESSA Pharma Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of ESSA Pharma on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of ESSA Pharma based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on ESSA Pharma price pattern first instead of the macroeconomic environment surrounding ESSA Pharma. By analyzing ESSA Pharma's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of ESSA Pharma's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to ESSA Pharma specific price patterns or momentum indicators. Please read more on our technical analysis page.
 2023 2024 (projected)
Net Current Asset Value770.5684.89
Days Payables Outstanding7.2K8.1K

ESSA Pharma November 30, 2024 Technical Indicators

Most technical analysis of ESSA help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for ESSA from various momentum indicators to cycle indicators. When you analyze ESSA charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Additional Tools for ESSA Stock Analysis

When running ESSA Pharma's price analysis, check to measure ESSA Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ESSA Pharma is operating at the current time. Most of ESSA Pharma's value examination focuses on studying past and present price action to predict the probability of ESSA Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ESSA Pharma's price. Additionally, you may evaluate how the addition of ESSA Pharma to your portfolios can decrease your overall portfolio volatility.